Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Receivables (2020 - 2025)

Historic Receivables for Cellebrite DI (CLBT) over the last 5 years, with Q4 2024 value amounting to $163.7 million.

  • Cellebrite DI's Receivables fell 164.86% to $163.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $163.7 million, marking a year-over-year decrease of 164.86%. This contributed to the annual value of $163.7 million for FY2024, which is 164.86% down from last year.
  • Latest data reveals that Cellebrite DI reported Receivables of $163.7 million as of Q4 2024, which was down 164.86% from $166.4 million recorded in Q4 2023.
  • Over the past 5 years, Cellebrite DI's Receivables peaked at $166.4 million during Q4 2023, and registered a low of $100.2 million during Q4 2020.
  • Moreover, its 5-year median value for Receivables was $160.3 million (2022), whereas its average is $146.1 million.
  • As far as peak fluctuations go, Cellebrite DI's Receivables surged by 3944.55% in 2021, and later crashed by 164.86% in 2024.
  • Quarter analysis of 5 years shows Cellebrite DI's Receivables stood at $100.2 million in 2020, then surged by 39.45% to $139.8 million in 2021, then rose by 14.69% to $160.3 million in 2022, then rose by 3.84% to $166.4 million in 2023, then dropped by 1.65% to $163.7 million in 2024.
  • Its Receivables stands at $163.7 million for Q4 2024, versus $166.4 million for Q4 2023 and $160.3 million for Q4 2022.